Variant Ciz1 is a circulating biomarker for early-stage lung cancer - Higgins, Gillian; Roper, Katherine M; Watson, Irene J; Blackhall, Fiona H; Rom, William N; Pass, Harvey I; Ainscough, Justin F. X; Coverley, Dawn (Proceedings of the National Academy of Sciences - PNAS, 2012)
Keywords: Adult; Aged; Alternative Splicing - genetics; Animals; Biological Sciences; biomarkers; Biomarkers, Tumor - blood; Biomarkers, Tumor - genetics; Carcinoma, Non-Small-Cell Lung - blood; Carcinoma, Non-Small-Cell Lung - genetics; Carcinoma, Non-Small-Cell Lung - pathology; Cell Line, Tumor; Cell Proliferation; Cells; Deoxyribonucleic acid; DNA; DNA replication; Female; Gene Expression Regulation, Neoplastic; Humans; Lung cancer; lung neoplasms; Lung Neoplasms - blood; Lung Neoplasms - genetics; Lung Neoplasms - pathology; Male; Mice; Middle Aged; neoplasm cells; Neoplasm Staging; NIH 3T3 Cells; Nuclear Proteins - blood; Nuclear Proteins - genetics; patients; Plasma; PNAS Plus; Proteins; Sensitivity and Specificity; Tumors; Western blotting